Urinary peptide levels in women with eating disorders. A pilot study

Eating and Weight Disorders

Volumn 8, Issue 1, 2003, Pages 55-61

  Hellzen M ^a   Larsson, J O ^a   Reichelt, K L ^b   Rydelius, P A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anorexia; Bulimia; Earing disorders; Urinary peptides

Indexed keywords

PEPTIDE;

ADULT; ANOREXIA; ARTICLE; BULIMIA; CASE CONTROL STUDY; EATING DISORDER; FEMALE; HUMAN; MULTIVARIATE ANALYSIS; PILOT STUDY; REGRESSION ANALYSIS; SWEDEN; URINE;

ADULT; ANOREXIA; BULIMIA; CASE-CONTROL STUDIES; EATING DISORDERS; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; PEPTIDES; PILOT PROJECTS; REGRESSION ANALYSIS; SWEDEN;

EID: 0038488342     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: 10.1007/BF03324989     Document Type: Article

References (30)

1. APA. Diagnostic and Statistical manual of mental disorders, Ed. 4 (DSM-IV). Washington, DC, APA Press, 1994.
2. Ward A., Tiller I, Treasure J., Russell G: Eating disorders: psyche or soma? Int. J. Eat. Disord., 27, 279-287, 2000.
3. Kipman A., Gorwood P., Mouren-Simeoni M.C., Ades J.: Genetic factors in anorexia nervosa. European Psychiatry. J. Assoc. European Psychiatrists, 14, 189-198, 1999.
4. Copeland P.M., Sacks N.R., Herzog D.B.: Longitudinal follow-up of amenorrhea in eating disorders. Psychosom. Med., 57, 121-126, 1995.
5. Klibanski A., Biller B.M., Schoenfeld D.A., Herzog D.B., Saxe V.C: The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J. Clin. Endocrinol. Metab., 80, 898-904, 1995.
6. Stacher G., Abatzi-Wenzel T.A., Wiesnagrotzki S., Bergmann H., Schneider C., Gaupmann G: Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride [see comments]. Br. J. Psychiatry, 162, 398-402, 1993.
7. de Simone G., Scalfi L., Galderisi M., Celentano A., Di Biase G., Tammaro P., et al: Cardiac abnormalities in young women with anorexia nervosa. Br. Heart J. 71, 287-292, 1994.
8. Müller B., Herpertz S., Heussen N., Neudorfl A., Wewetzer C, Remschmidt H., et al: Personality disorders and psychiatric morbidity in adolescent anorexia nervosa. Results of a prospective 10 year catamnesis. Z. Kinder Jugendpsychiatr., 28, 81-91, 2000.
9. Nilsson E.W, Gillberg C., Gillberg I.C., Rastam M.: Ten-year follow-up of adolescent-onset anorexia nervosa: personality disorders. J. Am. Acad. Child Adolesc. Psychiatry, 38, 1389-1395, 1999.
10. Godart N.T., Flament M.F., Lecrubier Y., Jeammet P: Anxiety disorders in anorexia nervosa and bulimia nervosa: co-morbidity and chronology of appearance. European Psychiatry. J. Assoc. Eur. Psychiatrists, 15, 38-45, 2000.
11. Favaro A., Santonastaso P.: Suicidality in eating disorders: clinical and psychological correlates. Acta Psychiatr. Scand., 95, 508-514, 1997.
12. Kaye V.M., Gendall K., Kye C: The role of the central nervous system in the psychoneuroen-docrine disturbances of anorexia and bulimia nervosa. Psychiatr. Clin. North Am., 21, 381-396, 1998.
13. Pirke K.M.: Central and peripheral noradrenalin regulation in eating disorders. Psychiatry Res., 62, 43-49, 1996.
14. Brewerton T.D.: Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinol., 20, 561-590, 1995.
15. Rockwell W.J., Nishita J.K., Ellinwood E.H. Jr.: Anorexia nervosa. Current perspectives in research. Psychiatr. Clin North Am., 7, 223-233, 1984.
16. Kaye V.M., Berrettini W., Gwirtsman H., George D.T.: Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch. Gen. Psychiatry, 47, 548-556, 1990.
17. Trygstad O.E. Reichelt K.L., Foss I., Edminson P.D., Saelid G., Bremer J., et al.: Patterns of peptides and protein-associated-peptide complexes in psychiatric disorders. Br. J. Psychiatry, 136, 59-72, 1980.
18. Yarbrough G.G.: TRH potentiates excitatory actions of acetylcholine on cerebral cortical neurones. Nature, 263, 523-524, 1976.
19. Versteeg D.H., Tanaka M., De Kloet E.R., Van Ree J.M., De Wied D.: Prolyl-leucyl glycinamide, (PLG); regional effects on alpha-MPT-induced catecholamine disappearance in rat brain. Brain Res., 143, 561-566, 1978.
20. Reichelt K.L., Foss I., Trygstad O., Edminson P.D., Johansen J.H., Boler J.B.: Humoral control of appetite-IL Purification and characterization of an anorexogenic peptide from human urine. Neuroscience, 3, 1207-1211, 1978.
21. Nance D.M., Coy D.H., Kastin A.L.: Experiments with a reported anorexigenic tripeptide: pyro-GIu-His-Gly-OH. Pharmacol. Biochem. Behav., 11, 733-735, 1979.
22. Bjorkman S., Karlsson J.A., Sievertsson H., Lewander T., Bowers C.Y.: Synthesis and lack of biological activity of GIu-His-Gly, a proposed anorexogenic peptide. Acta Pharm. Suec, 17, 130-136, 1980.
23. Bodlund O., Grann M., Ottosson H., Svanborg C: Validation of the self-report questionnaire DIP-Q in diagnosing DSM-IV personality disorders: a comparison of three psychiatric samples. Acta Psychiatr. Scand., 97, 433-439, 1998.
24. Bohlen P., Castillo F., Ling N., Guillemin R: Purification of peptides: an efficient procedure for the separation of peptides from amino acids and salt. Int. J. Pept. Protein Res., 16, 306-310, 1980.
25. Reichelt V.M., Ek J., Stensrud M., Reichelt K.L.: Peptide excretion in celiac disease. J. Pediatr. Gastroenterol. Nutr., 26, 305-309, 1998.
26. Stata. Stata User's Guide [Computer program ma-nual]. College Station, Stata Press, Texas, 1999.
27. Watanabe Y., Kojima-Komatsu T., Iwaki-Egawa S., Fujimoto Y.: Increased excretion of proline-containing peptides in dipeptidyl peptidase IV-deficient rats. Res. Commun. Chem. Pathol. Pharmacol., 81, 323-330, 1993.
28. Gardner M.L.G: Absorption of intact proteins and peptides. In: Johnson L.R. (Ed.), Physiology of the gastrointestinal tract. New York, Raven Press, 1994, pp. 1795-1820.
29. Maxton D.G., Menzies I.S., Slavin B., Thompson R.P.: Small-intestinal function during enteral feeding and starvation in man. Clin. Sci., 77, 401-406, 1989.
30. Husby S., Jensenius J.C., Svehag SE: Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies. Scand. J. Immunol., 22, 83-92, 1985.